Vericel Corporation

Vericel Corporationverified

VCEL

Price:

$46.35

Market Cap:

$2.27B

Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for the repair of symptomatic, and single or multiple full-thickness cartilage defects of the knee; and Epicel, a permanent skin replacement humanitarian use device for the treatment of adult and pediatric patients with deep-dermal or full-thickness burns. Its preapproval stage product is NexoBrid, a registration-stage biological orphan product for eschar ...[Read more]

Industry

Biotechnology

IPO Date

1997-02-04

Stock Exchange

NASDAQ

Ticker

VCEL

The Current Ratio as of September 2024 (TTM) for Vericel Corporation (VCEL) is 4.50

According to Vericel Corporation’s latest financial reports and current stock price. The company's current Current Ratio is 4.50. This represents a change of -7.11% compared to the average of 4.84 of the last 4 quarters.

Vericel Corporation (VCEL) Historical Current Ratio (quarterly & annually)

How has VCEL Current Ratio performed in the past?

The mean historical Current Ratio of Vericel Corporation over the last ten years is 4.74. The current 4.50 Current Ratio has changed 9.39% with respect to the historical average. Over the past ten years (40 quarters), VCEL's Current Ratio was at its highest in in the March 2019 quarter at 8.47. The Current Ratio was at its lowest in in the September 2016 quarter at 1.37.

Quarterly (TTM)
Annual

Average

4.74

Median

4.74

Minimum

2.26

Maximum

7.62

Vericel Corporation (VCEL) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Vericel Corporation Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 120.19%

Maximum Annual Current Ratio = 7.62

Minimum Annual Increase = -35.62%

Minimum Annual Current Ratio = 2.26

Quarterly (TTM)
Annual
YearCurrent RatioChange
20234.49-9.89%
20224.99-17.99%
20216.0810.68%
20205.50-2.57%
20195.64-26.02%
20187.6297.61%
20173.8610.88%
20163.4854.09%
20152.26-35.62%
20143.51120.19%

Vericel Corporation (VCEL) Average Current Ratio

How has VCEL Current Ratio performed in the past?

The current Current Ratio of Vericel Corporation (VCEL) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

5.19

5-year avg

5.34

10-year avg

4.74

Vericel Corporation (VCEL) Current Ratio vs. Peers

How is VCEL’s Current Ratio compared to its peers?

Vericel Corporation’s Current Ratio is less than CollPlant Biotechnologies Ltd. (6.27), less than Keros Therapeutics, Inc. (20.37), less than Merus N.V. (9.97), less than Century Therapeutics, Inc. (10.62), less than Chimerix, Inc. (6.94), greater than Day One Biopharmaceuticals, Inc. (4.09), less than X4 Pharmaceuticals, Inc. (6.07), less than Mereo BioPharma Group plc (6.07), less than Terns Pharmaceuticals, Inc. (21.02), less than IDEAYA Biosciences, Inc. (17.50), less than Syndax Pharmaceuticals, Inc. (10.50), less than Xencor, Inc. (6.92), greater than REGENXBIO Inc. (3.53), less than Crinetics Pharmaceuticals, Inc. (16.09), less than Stoke Therapeutics, Inc. (6.67), less than Pliant Therapeutics, Inc. (14.47), less than Dyne Therapeutics, Inc. (26.63), less than Cytokinetics, Incorporated (10.39), less than Revolution Medicines, Inc. (15.42), greater than Blueprint Medicines Corporation (3.71), less than Relay Therapeutics, Inc. (15.64),

Build a custom stock screener for Vericel Corporation (VCEL) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Vericel Corporation using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Vericel Corporation (VCEL) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Vericel Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Current Ratio?

How can you use the Current Ratio?

What is Vericel Corporation's Current Ratio?

How is the Current Ratio calculated for Vericel Corporation (VCEL)?

What is the highest Current Ratio for Vericel Corporation (VCEL)?

What is the 3-year average Current Ratio for Vericel Corporation (VCEL)?

What is the 5-year average Current Ratio for Vericel Corporation (VCEL)?

How does the current Current Ratio for Vericel Corporation (VCEL) compare to its historical average?